These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2953842)

  • 1. Prenatal diagnosis of recurrent Down's syndrome: a case report.
    Unakul W; Vantanasiri C; Makemaharn O; Karavagul C; Svivannaboon S
    J Med Assoc Thai; 1987 Feb; 70(2):102-5. PubMed ID: 2953842
    [No Abstract]   [Full Text] [Related]  

  • 2. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prospects for "preventing" Down's syndrome in an English region.
    Forster DP
    Rev Epidemiol Sante Publique; 1980 Dec; 28(4):423-30. PubMed ID: 6452660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary prevention of Down's syndrome in Czechoslovakia 1975-1980].
    Kucera J
    Cesk Pediatr; 1982 Jul; 37(7):404-8. PubMed ID: 6215132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early ultrasonic amniocentesis. 147 cases].
    Darconza G; Paradiso S; Trentadue R
    Minerva Ginecol; 1990 Mar; 42(3):55-8. PubMed ID: 2140149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrauterine diagnosis of G-G translocation].
    Papp Z; Gardó S; Méhes K
    Z Geburtshilfe Perinatol; 1972 Oct; 176(5):409-12. PubMed ID: 4264540
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cost-benefit analysis of the prevention of Down's syndrome by means of prenatal diagnosis during early pregnancy].
    Flatz VG
    Fortschr Med; 1978 Jun; 96(24):1255-6, 1295. PubMed ID: 149085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prenatal genetic diagnosis and Down's syndrome].
    Srsen S; Srsnová K
    Cesk Gynekol; 1986 May; 51(4):271-4. PubMed ID: 2941168
    [No Abstract]   [Full Text] [Related]  

  • 10. Antenatal diagnosis of fetal abnormality with special reference to amniocentesis.
    Turnbull AC; Gregory PJ; Laurence KM
    Proc R Soc Med; 1973 Nov; 66(11):1115-8. PubMed ID: 4273030
    [No Abstract]   [Full Text] [Related]  

  • 11. Making sense of maternal serum screening.
    Lindsay P
    Nurs Times; 1994 Dec 7-14; 90(49):30-2. PubMed ID: 7528377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Down's syndrome. Data do not support study's claim.
    Norgaard-Pedersen B
    BMJ; 2000 Sep; 321(7263):763; author reply 764-5. PubMed ID: 10999925
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytogenetic evaluation of fetal death: the role of amniocentesis.
    Saal HM; Rodis J; Weinbaum PJ; DiMaggio R; Landrey TM
    Obstet Gynecol; 1987 Oct; 70(4):601-3. PubMed ID: 2957622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis. Results of cytogenetic analysis of amniotic fluid cell cultures.
    Mulcahy MT; Jenkyn J
    Med J Aust; 1973 May; 1(20):979-82. PubMed ID: 4268556
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rapid prenatal diagnosis of Down's syndrome in the first trimester of pregnancy by fluorescence in situ hybridization].
    Xiang Y; Sun N; Wang F
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):646-8. PubMed ID: 9639761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.